USE IN SPECIFIC POPULATIONS : There are no data in patients below 18 years of age
[1] [4] These combined effects help improve glycaemic control and often result in weight loss
Impact on Weight and Metabolism Many breast cancer treatments, particularly chemotherapy, hormone therapy, and targeted therapies, can affect a patients weight and metabolism
Initial Bioimpedance Spectroscopy Results: Weight: 234 lbs Body Fat: 45.7% BMI: 33.4 Body Fat Mass: 109 lbs Lean Body Mass: 130 lbs Skeletal Muscle Mass: 71 lbs ECW/TBW (Extracellular Water/Total Body Water): 0.401 in both legs Rapid Improvements with GLP-1 Within just three weeks on Tirzepatide, JH noticed significant changes
In the final results from the three-year SURMOUNT-1 trial, tirzepatide lowered the risk of progression to Type 2 diabetes by 94% versus placebo in adult prediabetic patients who were obese or overweight
However, this increased efficacy comes with a trade-off: more pronounced gastrointestinal side effects, especially at the higher 15 mg dose
